# OnCo record idea-pu-sglt2-glp1-plan-before-pet (idea). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/ideas/idea-pu-sglt2-glp1-plan-before-pet/>
  a schema:CreativeWork ;
  onco:kind "idea" ;
  schema:identifier "idea-pu-sglt2-glp1-plan-before-pet" ;
  schema:name "A written plan for SGLT2 inhibitors and GLP-1 medicines before an FDG PET-CT scan"@en ;
  schema:description "PET-CT scans for cancer measure how much sugar tissues take up, and many people now take newer diabetes and weight-loss medicines that change sugar handling. The main European guideline predates their wide use and says nothing about them, while reports suggest they can blur parts of the scan. There is no agreed advice on whether to pause them."@en ;
  schema:url <https://onco.cc/ideas/idea-pu-sglt2-glp1-plan-before-pet/> ;
  schema:dateModified "2026-11-11"^^xsd:date ;
  schema:citation <https://doi.org/10.1007/s00259-014-2961-x>, <https://doi.org/10.1111/imj.70344>, <https://doi.org/10.1590/1806-9282.20260904>, <https://doi.org/10.1016/j.jacadv.2025.102016>, <https://doi.org/10.1186/s13550-026-01373-4>, <https://doi.org/10.1097/rlu.0000000000005318> ;
  onco:tag "protocol-upgrade", "upgrade:untested", "evidence:insufficient", "precision" ;
  onco:sections <https://onco.cc/fronts/imaging/> ;
  onco:technologies <https://onco.cc/technologies/fdg-pet/>, <https://onco.cc/technologies/pet-ct/> ;
  onco:institutions <https://onco.cc/institutions/eanm/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-knowledge-diffusion/> .